DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Zhou Y, Li R, Yan F, Lee JJ, Yuan Y.
A comparative study of Bayesian optimal interval (BOIN) design with interval 3+3 (i3+3) design for phase I oncology dose-finding trials.
Stat Biopharm Res 2021;
13 (02) 147-155
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.